Glicksman R, Kishan AU, Katz AJ, Mantz CA, et al. 4-Year PSA Response Rate as a Predictive Measure in Intermediate Risk Prostate Cancer Treated With Ablative Therapies: The Sprat Analysis. Int J Radiat Oncol Biol Phys 2021;111.
PMID: 34701066